Skip to main content
Skip to main content
TDAC logo

Translational Development Acquisition Corp. (TDAC) Stock Analysis

Educational signal · not a buy or sell recommendation · How to read this

$10.90 $0.00 (-0.09%) |Fair · 46
Translational Development Acquisition Corp. (TDAC) bottom line: Split View — our Council read (49/100) and AI Score (46/100) broadly agree. Strongest signal: Izzy Englander bullish · Biggest watch-out: Growth Durability weak.Educational signal, not a buy or sell recommendation. Compare sector peers → · Read the method →
MCap: $268M| P/E Ratio: 42.31| Vol: 7K| 52-wk range: $10.34 – $10.95

P/E 42.31 means the share price is 42.31 times one year of earnings per share; the S&P 500 usually sits near 20-25. Market cap $268M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 9, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Quick Answer

Translational Development Acquisition Corp. (TDAC) trades at $10.90 with MoonshotScore 46/100 (Grade C). Translational Development Acquisition Corp. is a shell company focused on identifying and merging with a private business. Market cap: $268M, Sector: Financial services.

Price as of Sep 11, 2026 · Last analyzed: May 9, 2026
Translational Development Acquisition Corp. is a shell company focused on identifying and merging with a private business. Incorporated in 2022, the company seeks to create value through a strategic business combination.

Analyst Coverage for TDAC: TDAC does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates TDAC against Financial Services peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.

Watch the TDAC film Every key number, told as a short cinematic story — just press play. ~2 min

These figures come from statements filed 12 months ago — the most recent this company has published.

Council Score · Weighted Average of 3 Disciplines
Split View 49/100 · C

TDAC: 1/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.

How is this calculated? →
MoonshotScore · Five-pillar engine · 46/100
Business Quality
Weak Is this a genuinely good business?
Financial Safety
Neutral Could this blow up on me?
Valuation
Weak Am I paying a fair price?
Growth Durability
Negative Is the growth real and likely to last?
Momentum
Moderate Is the market already moving on this?

Strongest side: Momentum (6/10, Moderate). Weakest side: Growth Durability (1/10, Negative).

Legends Council · 5 Legends + Moon AI

AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built

Dalio-style lens (simulated)Ray Dalio
Favorable read
Griffin-style lens (simulated)Ken Griffin
Unfavorable read
Simons-style lens (simulated)Jim Simons
Neutral read
Englander-style lens (simulated)Izzy Englander
Favorable read
Klarman-style lens (simulated)Seth Klarman
Favorable read
Moon AI lens (model)
Neutral read
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →
The lenses are modelled on the published principles of the investors named. We are not affiliated with them, they have not endorsed this, and it is not their opinion of this stock.

Why this analysis is different

  • A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Translational Development Acquisition Corp. (TDAC) Financial Services Profile

CEOMichael Hoffman
Employees2
HeadquartersNew York City, NY, US
IPO Year2025

Translational Development Acquisition Corp. is a special purpose acquisition company (SPAC) aiming to identify and merge with a private entity, offering investors exposure to a potentially high-growth business through a public listing, operating within the financial services sector and incorporated in 2022.

Data Provenance | Financial Data Quantitative Analysis NASDAQ Analysis: May 9, 2026

What Is the Investment Thesis for TDAC?

AI-written as of May 9, 2026 — figures and tone reflect the data available then, not today's score.

Investing in Translational Development Acquisition Corp. (TDAC) is speculative, as its value depends entirely on the successful identification and merger with a private company. The company's market capitalization is $268M. A successful merger could lead to significant returns if the acquired company performs well in the public market. However, potential investors face risks, including the possibility that TDAC may not find a suitable target or that the acquired company may underperform expectations. The company's beta is -0.01. The investment thesis hinges on the management team's expertise in identifying and executing a value-accretive transaction within a specified timeframe.

Based on FMP financials and quantitative analysis

TDAC Key Highlights

AI-written as of May 9, 2026 — figures and tone reflect the data available then, not today's score.

Market capitalization of $268M, reflecting investor valuation of the SPAC's potential acquisition target.

  • Incorporated in 2022, indicating a relatively new SPAC seeking a business combination.
  • Operates with a small team of 2 employees, highlighting the lean operational structure typical of SPACs.
  • P/E ratio of 42.31, which is not directly indicative of performance due to the SPAC's pre-acquisition status.
  • Beta of -0.01, suggesting a low correlation with overall market movements, typical for SPACs before a merger announcement.

Who Are TDAC's Competitors?

TDAC is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap MoonshotScore
RFAI RF Acquisition Corp II $32.00 -0.03% $267M 485-pillar
OACC Oaktree Acquisition Corp. III Life Sciences $10.82 +0.46% $266M 505-pillar
CEPV Cantor Equity Partners V, Inc. $10.41 +0.19% $266M 485-pillar
DMAA Drugs Made In America Acquisition Corp. $10.80 0.00% $262M 465-pillar
VNME Vendome Acquisition Corporation I $10.27 -0.10% $257M 525-pillar
RAC Rithm Acquisition Corp. $10.57 -0.28% $250M 505-pillar
COPL Copley Acquisition Corp $10.54 -0.28% $250M 485-pillar
CRAQ Cal Redwood Acquisition Corp. $10.39 +0.10% $246M 485-pillar

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are TDAC's Key Strengths?

Experienced management team (if applicable).

  • Access to capital raised through the IPO.
  • Flexibility to target companies in various industries.
  • Potential for high returns if a successful merger is completed.

What Are TDAC's Weaknesses?

Dependence on finding a suitable acquisition target.

  • Limited operating history.
  • Potential for conflicts of interest between management and shareholders.
  • Dilution of shareholder value if additional capital is raised.

What Could Drive TDAC Stock Higher?

Announcement of a definitive merger agreement with a target company.

  • Successful completion of due diligence on potential target companies.
  • Favorable market conditions for SPAC mergers.

What Are the Key Risks for TDAC?

Weak fundamentals — a Piotroski F-Score of 3/9 flags soft profitability, leverage or efficiency.

  • Rich valuation — a P/E of 42.31 runs well above the Financial Services sector’s ~17.50x, leaving little room for a miss.
  • Insider selling — insiders were net sellers of roughly $8.6M recently.
  • Failure to find a suitable acquisition target within the specified timeframe.
  • Regulatory changes impacting the SPAC market.
  • Economic downturn or market volatility.
  • Increased competition from other SPACs.

What Are the Growth Opportunities for TDAC?

  • Successful Acquisition: The primary growth opportunity for TDAC lies in its ability to identify and merge with a high-growth private company. The market size of potential target companies is vast, spanning various industries. A well-chosen target with strong fundamentals and growth prospects could drive significant shareholder value post-merger. Timeline: Within the next 12-24 months.
  • Favorable Market Conditions: Improved market sentiment and investor appetite for SPAC mergers could create a more conducive environment for TDAC to complete a successful transaction. Positive market conditions can lead to higher valuations and increased investor interest in the merged entity. Market size: Dependent on overall market capitalization and investor confidence. Timeline: Ongoing.
  • Strategic Sector Focus: Focusing on a specific high-growth sector, such as technology or healthcare, could increase TDAC's chances of finding an attractive target. Specializing in a particular sector allows the management team to leverage their expertise and network to identify promising opportunities. Market size: Varies by sector. Timeline: Ongoing.
  • Operational Efficiency Post-Merger: Implementing operational improvements and cost synergies within the acquired company could enhance profitability and drive shareholder value. Efficient integration and execution are crucial for realizing the full potential of the merger. Market size: Dependent on the acquired company's financials. Timeline: Post-merger.
  • Attracting Institutional Investors: Securing commitments from institutional investors prior to the merger could provide additional capital and validation for the transaction. Institutional support can improve the long-term stability and performance of the merged entity. Market size: Institutional investment in SPACs. Timeline: Pre- and post-merger.

What Opportunities Does TDAC Have?

  • Growing demand for alternative investment opportunities.
  • Increasing number of private companies seeking to go public.
  • Favorable market conditions for SPAC mergers.
  • Potential to acquire a disruptive or high-growth company.

What Are TDAC's Competitive Advantages?

  • Management team's experience and network in identifying and executing successful mergers.
  • Access to capital raised through the IPO.
  • Speed and efficiency in completing a merger compared to a traditional IPO.
  • Flexibility to target companies in various industries.

What Does TDAC Do?

Translational Development Acquisition Corp. (TDAC) is a special purpose acquisition company (SPAC) formed in 2022 and based in New York City. As a shell company, TDAC's primary purpose is to identify and merge with a private company, effectively taking the target company public without the traditional IPO process. TDAC was incorporated with the intention of pursuing a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Unlike operating companies with established products or services, TDAC exists solely to find a suitable acquisition target. The company's success hinges on its management team's ability to identify a promising private company with strong growth potential and negotiate a favorable merger agreement. Once a target is identified, TDAC will typically seek shareholder approval for the proposed merger. If approved, the private company will become a publicly traded entity under the TDAC ticker symbol or a new ticker symbol, depending on the terms of the agreement. TDAC does not have significant operations, with its activities primarily focused on due diligence, negotiation, and regulatory compliance related to potential acquisitions.

What Products and Services Does TDAC Offer?

  • Identify potential private companies for a merger or acquisition.
  • Conduct due diligence on target companies.
  • Negotiate merger agreements.
  • Seek shareholder approval for the proposed merger.
  • Complete the merger transaction, taking the target company public.
  • Manage the transition and integration of the acquired company.

How Does TDAC Make Money?

  • Raise capital through an initial public offering (IPO).
  • Use the IPO proceeds to fund the acquisition of a private company.
  • Generate returns for shareholders through the appreciation of the merged company's stock price.
  • Management team typically receives a percentage of the merged company's equity as compensation.

What Industry Does TDAC Operate In?

Translational Development Acquisition Corp. operates within the shell company industry, specifically as a special purpose acquisition company (SPAC). The SPAC market has experienced periods of rapid growth and increased scrutiny. SPACs offer private companies an alternative route to public listing compared to traditional IPOs. The success of a SPAC depends heavily on the quality of the target company it acquires and the prevailing market conditions at the time of the merger. The industry is characterized by high competition among SPACs seeking attractive targets, and regulatory changes can significantly impact the SPAC landscape.

Who Are TDAC's Key Customers?

  • Institutional investors seeking exposure to private equity-like returns.
  • Retail investors interested in participating in potential high-growth opportunities.
  • Private companies seeking a faster and less expensive route to public listing compared to a traditional IPO.
Model self-rating on this text: 68% (not a measure of the evidence) Updated: May 9, 2026

Research confidence

High 85/100

Broad, current evidence sits behind this analysis.

  • Scored on 100% of our measures
  • Price is current
  • Latest filing 28 days ago
  • No analyst coverage

Why 46?

Measured against companies in the same sector. The figures below are the factor contributions the scoring engine itself produced.

What is helping

  • +0.41 Return on assets (Business Quality)
  • +0.35 Earnings growth (Growth)
  • +0.14 Volatility vs the market (Financial Strength)

What is holding it back

  • -0.48 Revenue growth (Growth)
  • -0.48 5-year revenue per share (Growth)
  • -0.48 Share dilution (Growth)

Contribution = how far the company sits from its sector on that measure, weighted by how much the pillar counts. Not investment advice. How the score is built →

MoonshotScore History

Recorded daily since 2026-08-23 · 19 snapshots

2026-08-23 43
2026-08-26 43
2026-08-29 43
2026-09-01 46
2026-09-04 45
2026-09-07 46
2026-09-10 46

What changed?

The grade moved from 43 to 46 (+3).

What moved it up or down:

  • +32 Financial Safety
  • +3 Momentum
  • +1 Business Quality

Held back by:

  • -4 Growth Durability
  • -3 Valuation

Over the same 18 days the stock moved +0.5%.

Company Profile

Translational Development Acquisition Corp. operates in the Shell Companies industry within the Financial Services sector. It is headquartered in New York City, US. The company is led by CEO Michael Hoffman. TDAC has traded publicly since 2025.

ROE 3%

Key Financial Metrics

Return on equity for Translational Development Acquisition Corp. stands at 3.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 3.5%, showing how much profit it generates from its asset base. TDAC trades at a trailing price-to-earnings ratio of 42.31, above the Financial Services sector average of ~17.50x. Its free cash flow yield is -0.3%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.06 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 3.0%, the inverse of the P/E and a quick read on earnings relative to price.

TDAC Valuation & Market Position

With a $268M market cap, Translational Development Acquisition Corp. sits in the micro-cap segment of the market. Relative to its peer group, TDAC's quantitative score of 46/100 is roughly in line with the peer average of 49/100.

Quarterly Financial Performance: Translational Development Acquisition Corp.

Revenue for Translational Development Acquisition Corp. came in at $0 during Q2 FY2026. The company recorded net income of $947K, with diluted EPS of $0.06. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Financial Services. Across the four most recent quarters, TDAC averaged $0.08 in diluted EPS.

F-Score 3/9

Financial Health

Translational Development Acquisition Corp.'s Piotroski F-Score is 3/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of 20.57 places it in the safe zone, indicating low near-term bankruptcy risk.

Net selling

Insider Activity

The most recent 5 insider filings for Translational Development Acquisition Corp. break down as 4 sales and 1 purchases. On net that is roughly 720K shares disposed (about $8.6M), a signal worth weighing alongside the fundamentals.

TDAC Financials

Fundamental Snapshot

Revenue Growth (FY)
-100.0%
Free Cash Flow Growth (FY)
+28.5%
P/E (TTM)
42.31
Return on Equity (TTM)
+3.3%
Current Ratio
0.1

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Experienced management team (if applicable).
  • Access to capital raised through the IPO.
  • Flexibility to target companies in various industries.
  • Potential for high returns if a successful merger is completed.

Bear Case

  • Dependence on finding a suitable acquisition target.
  • Limited operating history.
  • Potential for conflicts of interest between management and shareholders.
  • Dilution of shareholder value if additional capital is raised.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · September 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q2 FY2026 $0 $946,982 $0.06
Q1 FY2026 $0 $1M $0.08
Q4 FY2025 $0 $2M $0.09
Q3 FY2025 $0 $2M $0.10

Q2 FY2026 · filed 14 Aug 2026 · SEC EDGAR →

Based on FMP financials and quantitative analysis

TDAC Latest News

TDAC Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for TDAC.

Price Targets

Wall Street price target analysis for TDAC.

TDAC MoonshotScore

46/100

What does this score mean?

MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. TDAC scores 46/100 (Grade C): the number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.

Leadership: Michael Hoffman

Managing

Michael Hoffman is the managing person for Translational Development Acquisition Corp., overseeing a small team of two employees. His role involves leading the company's efforts to identify and execute a merger with a private company, a process that requires strong financial acumen and deal-making skills.

Track Record: Due to the nature of Translational Development Acquisition Corp. as a SPAC formed in 2022, Michael Hoffman's track record is limited to the company's activities since its inception. There is no information available regarding specific achievements or milestones under his leadership. His success will be determined by his ability to identify and complete a value-accretive merger transaction.

Common Questions About TDAC (Financial Services)

What does the AI Score mean for TDAC?

TDAC holds an AI Score of 46/100 (Grade: C). This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers. Translational Development Acquisition Corp. is a shell company focused on identifying and merging with a private business.

Is TDAC a good stock?

Stock Expert AI does not rate TDAC buy, sell or hold. Translational Development Acquisition Corp. carries a MoonshotScore of 46/100 on the five-pillar engine, a research rating against its peers. Whether it fits is your call: check what it sells, whether it earns, what the price assumes, and what would prove you wrong.

What does Translational Development Acquisition Corp. do?

Translational Development Acquisition Corp. is a special purpose acquisition company (SPAC). It does not have any operating business. It was formed to raise capital through an initial public offering (IPO) with the sole purpose of acquiring or merging with an existing private company. The goal is to take the private company public without the traditional IPO process.

What do analysts say about TDAC stock?

As of 2026-05-09, there is limited to no analyst coverage specifically for Translational Development Acquisition Corp. (TDAC) due to its nature as a SPAC prior to announcing a merger target.

What are the key factors to evaluate for TDAC?

Translational Development Acquisition Corp. (TDAC) holds a MoonshotScore of 46/100 (low). P/E: 42.31x vs the S&P 500's ~20-25x. Not financial advice.

How frequently does TDAC data refresh on this page?

TDAC's price was last updated on Sep 11, 2026 and refreshes on page view during U.S. market hours; the quote is a provider snapshot, not an exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven TDAC's recent stock price performance?

Translational Development Acquisition Corp. (TDAC) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Experienced management team (if applicable). See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider TDAC overvalued or undervalued right now?

Translational Development Acquisition Corp. (TDAC) trades at 42.31x earnings. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Can I buy fractional shares of TDAC?

Yes, most major brokerages offer fractional shares of Translational Development Acquisition Corp. (TDAC) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated MoonshotScore as of
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Information is based on publicly available sources and may be subject to change.
  • The analysis is limited by the lack of specific information regarding potential acquisition targets.
  • Investment in SPACs involves significant risks and should be undertaken with caution.
Data Sources
Financial Modeling Prep (FMP)Stock Expert AI proprietary analysis

More Stocks We Cover